Form EFFECT Sunshine Biopharma Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 7, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kingfisher Completes 2026 Drill Program at HWY 37 Project with 13,551 m Drilled, Golden Triangle
- FreeCast Named 2026 Streaming Technology Platform Company of the Year by Media & Entertainment Business Review
- eSUN Unveils TPE-95A: High-Rebound 3D Printing Filament with Up to 58% Rebound
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share